Find the Perfect Plan for Your Investment Journey
I
Last Price
52 Week Range
CA$1.88 - CA$10.56
Next Earnings Date
May 06 2025
Next Earnings Date
May 06 2025
Last Price
Market Cap | CA$6.63M |
EV | CA$21.69M |
Shares Outstanding | 3.09M |
Beta | 2.81 |
Analyst Rating | OUTPERFORM |
Analyst Target Price | CA$20.70 |
P/E 2025E | - |
P/Revenue 2025E | 0.09x |
Revenue | -0.20% |
EPS | 37.40% |
Operating Cash Flow | 68.50% |
Free Cash Flow | 44.20% |
Revenue | - |
EPS | - |
Operating Cash Flow | - |
Free Cash Flow | - |
Gross Margin 2025E | - |
Net Profit Margin 2025E | -1.38% |
ROE 2025E | - |
ROCE 2024 | -107.40% |
DPS 2025E | - |
Payout Ratio 2025E | - |
Div. Yield 2025E | - |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
I
IM Cannabis Corp.
IMCC
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Shuster, Oren
Employees
95
Website
imcannabis.comIPO Date
1996-08-08
Headquarters
Kibbutz Glil Yam, Central District, Tel Aviv 4690500, Israel
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved